We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 1.28% | 3.95 | 3.80 | 4.10 | 3.95 | 3.90 | 3.90 | 306,655 | 15:57:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 3.19M | -6.49M | -0.0122 | -3.24 | 20.8M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/8/2024 07:44 | Smith goes out of his way to wind up Erinvale by reminding us that the new guy will also have a desk; Eden Research CEO on German approval for Mevalone, new head of regulatory affairs | supersonico | |
17/8/2024 23:39 | Plant Health R&D presentation: GreenLight Biosciences | supersonico | |
17/8/2024 21:48 | No idea who you are referring too or the meaning behind it. | kittybiscuits | |
17/8/2024 21:39 | suki lost his pennies with his marbles. | neutralpov | |
17/8/2024 10:47 | You really have not pieced it together yet have you? One day the penny will drop. | kittybiscuits | |
17/8/2024 06:30 | Ha ha - just goes to show how wrong you are. Timbo might have held a lot when the price was 20p, whereas my holding at that time was tiny. Your obsession with prison and suicide really is rather worrying. | kittybiscuits | |
16/8/2024 16:59 | Only one person on this board looking stupid and it’s NPOV. | kittybiscuits | |
16/8/2024 16:21 | Who is "suki"? Stop speaking in riddles, subsonic. ----------- > I think Eden's fortunes are changing (a) Don't think. You're not genetically equipped for it. (b) No fix, let alone cure, for stooopid. :D | neutralpov | |
16/8/2024 11:38 | No it is not all tied up witb Corteva and that's why I think Eden's fortunes are changing with Sipcam aggressively selling and the insecticide to come. I would place that with anyone BUT Corteva. | money never sleeps | |
16/8/2024 09:42 | GKN didn't employ salesmen to sell BL cars because they had GKN propeller shafts . But HP Dell and others were Happy to have Intel Inside.The CFO did say to me at AGM agreements struck so that EDENs name on product labels.As to the sales discussion here it's getting very interesting | alchemy | |
16/8/2024 07:34 | But surely as they have all the distribution tied up with Corteva, who do have the aforementioned resources, they should be selling bucketloads. One has to question why not. Big red flag. | ravenna23 | |
16/8/2024 00:24 | Erinvale I've listened to what you have said and I agree there is an issue about how to push sales more effectively but I don't think your plan is a realistic answer. How do you respond to the points I have raised? | money never sleeps | |
15/8/2024 20:20 | Erinvale, I feel you like to enjoy criticising Eden management but when asked basic questions you avoid disclosure and subjecting yourself to the same scrutiny you like to apply to Eden management. Over and Out. | supersonico | |
15/8/2024 18:43 | SUMMARY OF WHAT ERINVALE1 AND RAVENNA23 WROTE TODAY :- If you are so foolish as to be a holder, SELL IT ALL while you still can. IF YOU ARE ATTRACTED TO BUYING INTO IT :- You are far too stupid, like the bigger PIs here, to be in the stockmarket at all. Seek paid help as you probably need professional mental health help. ~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~ SUMMARY OF WHAT THE OTHERS WROTE :- I wouldn't bother summarising. They are at best seriously deluded and extraordinarily thick, at worst ramping scum either of the ToroTrapped variety or indeed PAID TO LIE. Ignore, block, report to the FCA citing reference 2022/SG303/A | neutralpov | |
15/8/2024 18:29 | I feel that I have said what is relevant. The important issue, which the company fails to address, is how to deliver increased sales. Agreements with distributors, in-house labs and tech staff are not, as Sean Smith appears to believe, a route to selling product. A clear strategy is needed. Eden do not have one. Over and out! | erinvale1 | |
15/8/2024 18:08 | Erinvale, Some years ago? Care to be more precise so I can understand your proposal in the context of Eden's evolution etc? | supersonico | |
15/8/2024 16:53 | Supersonico: some years ago, when I was still involved with Eden, albeit tangentially. In this market, it seemed to me the only cost-effective plan given Eden’s size and financial position. | erinvale1 | |
15/8/2024 16:30 | When was this free sample strategy discussed Erinvale..? | supersonico | |
15/8/2024 16:19 | Kitty, in general that is correct. However, targeting carefully selected top producers in prime regions would be perfectly feasible and, in my view, cost effective. Eden would not be touting alternatives to existing products - there are none - but introducing proven natural remedies for frequent bio problems which damage crops, reduce quality and hit profits. The wine estates I would recommend as a focus are internationally recognised top-class outfits, whose products sell out at top prices; they are run by highly intelligent people. It is hard to see why they would not accept a free trial sample. | erinvale1 | |
15/8/2024 16:09 | Penetration into the market like that is hugely costly and time consuming. I suspect that is why. Eden are not big enough to support such a costly operation. | kittybiscuits |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions